This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Dayong Guo: Innovator in Genetic Engineering
Introduction
Dayong Guo is a prominent inventor based in Overland Park, KS (US). He has made significant contributions to the field of genetic engineering, particularly in the development of non-human animals expressing humanized CD3 proteins. With a total of 4 patents to his name, Guo's work is paving the way for advancements in biomedical research.
Latest Patents
Guo's latest patents focus on non-human animals that express humanized CD3 complex. These patents detail genetically modified rodents that incorporate humanized CD3 proteins within their genome. The patents also include methods and compositions for creating such non-human animals, as well as various applications for their use in research and therapeutic settings.
Career Highlights
Currently, Dayong Guo is employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate and contribute to the field of biotechnology. His work is instrumental in advancing the understanding of immune responses and developing new therapeutic strategies.
Collaborations
Some of Guo's notable coworkers include Andrew J. Murphy and Kara Olson, who collaborate with him on various projects within the company.
Conclusion
Dayong Guo's innovative work in genetic engineering and his contributions to the development of humanized CD3 proteins highlight his importance in the field. His patents and ongoing research at Regeneron Pharmaceuticals, Inc. are set to make a lasting impact on biomedical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile